97-31215. Ashland Chemical Co.; Withdrawal of Food Additive Petition  

  • [Federal Register Volume 62, Number 229 (Friday, November 28, 1997)]
    [Notices]
    [Page 63347]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-31215]
    
    
    
    [[Page 63347]]
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 97F-0035]
    
    
    Ashland Chemical Co.; Withdrawal of Food Additive Petition
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing the 
    withdrawal, without prejudice to a future filing, of a food additive 
    petition (FAP 6A4490) proposing that the food additive regulations be 
    amended to provide for the safe use of polypropylene glycol with a 
    molecular weight of 1,200 to 3,000 as a defoaming agent in water for 
    sliced potatoes.
    
    FOR FURTHER INFORMATION CONTACT: Vivian M. Gilliam, Center for Food 
    Safety and Applied Nutrition (HFS-215), Food and Drug Administration, 
    200 C St. SW., Washington, DC 20204, 202-418-3167.
    
    SUPPLEMENTARY INFORMATION: In a notice published in the Federal 
    Register of February 3, 1997 (62 FR 5011), FDA announced that a food 
    additive petition (FAP 6A4490) had been filed by Ashland Chemical Co., 
    One Drew Plaza, Boonton, NJ 07005. The petition proposed to amend the 
    food additive regulations in Sec. 173.340 Defoaming agents (21 CFR 
    173.340) to provide for the safe use of polypropylene glycol with a 
    molecular weight of 1,200 to 3,000 as a component of defoaming agents 
    in wash water for sliced potatoes. Ashland Chemical Co. has now 
    withdrawn the petition without prejudice to a future filing (21 CFR 
    171.7).
    
        Dated: November 10, 1997.
     Laura M. Tarantino,
     Acting Director, Office of Premarket Approval.
    [FR Doc. 97-31215 Filed 11-26-97; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
11/28/1997
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
97-31215
Pages:
63347-63347 (1 pages)
Docket Numbers:
Docket No. 97F-0035
PDF File:
97-31215.pdf